{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson says he is 'on road to recovery' following hospitalization, but is uncertain when he will return to work.", "type_of_material": "News", "word_count": "350", "lead_paragraph": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "pub_date": "2016-01-26T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Chief Says Timing of His Return to Work Is Unclear", "print_headline": "Timing of Return to Work Is Unclear for Valeant Chief"}, "snippet": "J. Michael Pearson, who is also Valeant\u2019s chairman, was hospitalized in late December with what the pharmaceutical giant has described as pneumonia.", "multimedia": [{"height": 126, "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 450, "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "450", "xlarge": "images/2016/01/26/business/26valeant-web1/26valeant-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/01/26/business/26valeant-web1/26valeant-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/01/26/business/valeant-chief-michael-pearson.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pearson, John Michael (1959- )", "name": "persons"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Ingram, Robert A", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Schiller, Howard B", "name": "persons"}], "blog": [], "_id": "56a6283e38f0d81529067dfc", "source": "The New York Times"}